Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection

Zarebska-Michaluk, D; Jaroszewicz, J; Parfieniuk-Kowerda, A; Pawlowska, M; Janczewska, E; Berak, H; Janocha-Litwin, J; Klapaczynski, J; Tomasiewicz, K; Piekarska, A; Krygier, R; Citko, J; Tronina, O; Dobrowolska, K; Flisiak, R

Zarebska-Michaluk, D (通讯作者)，Jan Kochanowski Univ Humanities & Sci, Dept Infect Dis, PL-25516 Kielce, Poland.;Flisiak, R (通讯作者)，Med Univ Bialystok, Dept Infect Dis & Hepatol, PL-15540 Bialystok, Poland.

JOURNAL OF CLINICAL MEDICINE, 2022; 11 (2):

Abstract

The introduction of the direct-acting antivirals (DAA) has substantially improved the effectiveness of the therapy in patients with chronic hepatitis ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索